NCT04023227 Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC Status COMPLETED Phase PHASE4
NCT04005352 Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) Status COMPLETED Phase PHASE3
NCT04000529 Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies Status TERMINATED Phase PHASE1
NCT03989635 Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. Status WITHDRAWN Phase PHASE2
NCT03988634 Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) Status COMPLETED Phase PHASE3
NCT03988608 Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects. Status COMPLETED Phase PHASE2
NCT03977649 A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients Status COMPLETED Phase PHASE4
NCT03975829 Pediatric Long-Term Follow-up and Rollover Study Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03968419 This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. Status TERMINATED Phase PHASE2
NCT03966651 A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors. Status COMPLETED Phase PHASE1
NCT03961971 Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03960840 Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03955445 Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN Status RECRUITING Phase PHASE3
NCT03954626 Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD Status COMPLETED Phase PHASE3
NCT03948334 A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients Status TERMINATED Phase PHASE2
NCT03946670 A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS). Status TERMINATED Phase PHASE2
NCT03945318 Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) Status COMPLETED Phase PHASE1/PHASE2
NCT03944707 Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients Status TERMINATED Phase PHASE2